Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) rises 0.92% intraday, NAV per unit at HK$15.311

NewTimeSpace News: As of 14:20 on August 17, 2026, Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) rose 0.92% to HK$15.410. The ETF traded 11,750,400 shares with a turnover value of HK$181 million, an average transaction price of HK$15.382, a volume ratio of 2.27, a turnover rate of 7.00% and an amplitude of 3.14%. Its current net asset value per unit stands at HK$15.311, asset size reaches HK$2.57 billion, and each board lot comprises 100 shares.

Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) tracks the Hang Seng Biotech Index. It focuses on leading Hong Kong-listed biotech companies covering innovative drugs, CXO, vaccines, gene therapy and other segments.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.